Avadel
Clinical trials sponsored by Avadel, explained in plain language.
-
New narcolepsy Drug's Real-World impact tracked in patient study
Disease control CompletedThis study observed how patients with narcolepsy responded to LUMRYZ treatment in everyday clinical practice. Over 70 adults who were prescribed LUMRYZ completed questionnaires about their sleepiness, symptoms, and quality of life for four months. The goal was to understand how t…
Sponsor: Avadel • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New One-Dose-Nightly pill tested for narcolepsy safety
Disease control CompletedThis study tested the long-term safety and tolerability of a new, once-nightly version of a narcolepsy medication called FT218. It involved 184 people with narcolepsy, including those already taking a similar twice-nightly drug and those new to this type of treatment. The main go…
Phase: PHASE3 • Sponsor: Avadel • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC